Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1327 clinical trials
6-Month Outcomes of PEMF to Nucleotide Sources Revealing Cell Sensory Experience in Pain Relief Stress Relief and Anti Ageing Restoration

Here we report baseline characteristics, PEMF transfer events and outcomes in participants in the UK. This study serves as a calibration proforma for downstream real world evidence observations of PEMF in the field.

anxiety
pain relief
  • 0 views
  • 19 Feb, 2024
  • 1 location
Efficacy of Chemopreventive Agents on Disease-free and Overall Survival in Patients With Pancreatic Ductal Adenocarcinoma: The CAOS Study

The evidence on the value of aspirin, statins, metformin, beta-blocking ACE inhibitors agents as chemopreventive agents in patients with pancreatic ductal adenocarcinoma is limited. The aim of this study is to assess whether regular use of aspirin, statins, metformin, angiotensin converting enzyme (ACE)-inhibitors and beta-blocking agents use, before diagnosis, after …

adjuvant therapy
metformin
metastasis
adenocarcinoma
breast ductal carcinoma
  • 0 views
  • 24 Nov, 2025
  • 1 location
Multiple Myeloma and Environmental Exposure to Pesticides in the French West Indies: A Population Based Case-control Study.

The French West Indies departments of Guadeloupe and Martinique are characterized by a wide use of pesticides related to bananas plantation, particularly chlordecone which has been classified by IARC as possibly carcinogenic and has recognized hormonal properties (endocrine disruptor). The objective of this study is to measure the association between …

monoclonal protein
monoclonal antibodies
immunoglobulins
multiple myeloma
cancer
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Genetics of COVID-19 Susceptibility and Manifestations

Objective To learn more about COVID-19 by studying the DNA of people who have tested positive for it, and to share data as fast as possible with other qualified researchers who are also trying to learn more about COVID-19. Eligibility People ages 3 years and older who have tested positive …

covid-19
acute respiratory syndrome (sars)
organ failure
SARS
pneumonia
  • 0 views
  • 19 Feb, 2024
  • 1 location
COVID-19 Among Healthcare Workers in Belgian Hospitals

Additionally the study will validate serological tests (subject to change/addition depending on the evolution of scientific research) against the plaque reduction neutralization test (PRNT) (gold standard); validate the saliva sample (sampling with Oracol or equivalent) against the standard naso/oro pharyngeal swabbing (NOPS) to perform RT-qPCR for SARS-CoV-2 diagnostic purposes, as

nasal swab
serologic test
viral shedding
SARS
covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location
Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic

Thus, we intended to select them as our population to study how the level of anxiety during pandemic could affect the practice of oral hygien

covid-19
anxiety
dental care
confusion
symptoms of stress
  • 0 views
  • 19 Feb, 2024
  • 1 location
Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors

Eligibility People age 2 and older who have or are suspected to have a medical condition for which they have been referred to NIH s National Heart, Lung, and Blood Institute, as well as stem cell donors Design Participants may be screened with a review of the following: Medical records …

urine test
x-rays
apheresis
  • 0 views
  • 19 Feb, 2024
  • 1 location
Predictors of Better Outcomes After Severe Acquired Brain Injuries

Severe Acquired Brain Injury is defined as a traumatic, post-anoxic, vascular or other brain damage that causes coma for at least 24 hours and leads to permanent disability with sensorial, motor, cognitive or compartmental impairment.

traumatic brain injury
genetic analysis
perinatal brain injury
coma
bdnf
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Prospective Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …

complete resection
carcinoma
refractory multiple myeloma
multiple myeloma
cancer
  • 0 views
  • 19 Feb, 2024
  • 11 locations
A Prospective Non-interventional Multinational Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Primary Objective: To assess the effectiveness, in terms of overall response rate (ORR) of isatuximab patients with RRMM in routine clinical practice, within 12 months To assess other effectiveness parameters such as progression free survival (PFS), PFS rate (PFSR), duration of response (DoR), time to response, time and intent to …

complete resection
multiple myeloma
carcinoma
refractory multiple myeloma
line of therapy
  • 0 views
  • 19 Feb, 2024
  • 4 locations